A detailed history of Lazard Asset Management LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Lazard Asset Management LLC holds 7,254,033 shares of BSX stock, worth $656 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares
7,254,033
Previous 7,513,514 3.45%
Holding current value
$656 Million
Previous $579 Million 5.06%
% of portfolio
0.89%
Previous 0.79%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$72.96 - $84.0 $18.9 Million - $21.8 Million
-259,481 Reduced 3.45%
7,254,033 $608 Million
Q2 2024

Aug 14, 2024

BUY
$67.33 - $77.71 $5.63 Million - $6.5 Million
83,675 Added 1.13%
7,513,514 $579 Million
Q1 2024

May 14, 2024

SELL
$57.6 - $68.62 $80.5 Million - $96 Million
-1,398,409 Reduced 15.84%
7,429,839 $509 Million
Q4 2023

Feb 14, 2024

SELL
$48.64 - $57.81 $3.84 Million - $4.56 Million
-78,889 Reduced 0.89%
8,828,248 $510 Million
Q3 2023

Nov 14, 2023

SELL
$50.19 - $54.68 $14.3 Million - $15.6 Million
-285,441 Reduced 3.11%
8,907,137 $470 Million
Q2 2023

Aug 14, 2023

SELL
$49.72 - $54.64 $111 Million - $122 Million
-2,226,793 Reduced 19.5%
9,192,578 $497 Million
Q1 2023

May 15, 2023

SELL
$45.09 - $50.03 $58 Million - $64.3 Million
-1,286,098 Reduced 10.12%
11,419,371 $571 Million
Q4 2022

Feb 14, 2023

BUY
$39.56 - $47.22 $6.56 Million - $7.83 Million
165,750 Added 1.32%
12,705,469 $588 Million
Q3 2022

Nov 14, 2022

SELL
$36.71 - $109.66 $4.16 Million - $12.4 Million
-113,333 Reduced 0.9%
12,539,719 $486 Million
Q2 2022

Aug 09, 2022

BUY
$35.24 - $47.1 $85.2 Million - $114 Million
2,416,974 Added 23.61%
12,653,052 $472 Million
Q1 2022

May 13, 2022

BUY
$40.9 - $45.1 $13.8 Million - $15.2 Million
336,929 Added 3.4%
10,236,078 $453 Million
Q4 2021

Feb 09, 2022

BUY
$38.07 - $44.87 $6.73 Million - $7.93 Million
176,763 Added 1.82%
9,899,149 $421 Million
Q3 2021

Nov 15, 2021

BUY
$41.23 - $45.88 $577,384 - $642,503
14,004 Added 0.14%
9,722,386 $422 Million
Q2 2021

Aug 12, 2021

SELL
$38.58 - $44.24 $4.77 Million - $5.47 Million
-123,618 Reduced 1.26%
9,708,382 $415 Million
Q1 2021

May 14, 2021

BUY
$35.27 - $39.67 $9.76 Million - $11 Million
276,703 Added 2.9%
9,832,000 $380 Million
Q4 2020

Feb 11, 2021

BUY
$33.15 - $41.97 $30.5 Million - $38.6 Million
919,471 Added 10.65%
9,555,297 $344 Million
Q3 2020

Nov 13, 2020

BUY
$34.44 - $42.23 $98.4 Million - $121 Million
2,856,714 Added 49.43%
8,635,826 $330 Million
Q2 2020

Aug 13, 2020

BUY
$30.19 - $39.11 $125 Million - $162 Million
4,147,408 Added 254.18%
5,779,112 $203 Million
Q1 2020

May 14, 2020

SELL
$25.83 - $45.71 $2.49 Million - $4.41 Million
-96,373 Reduced 5.58%
1,631,704 $53.2 Million
Q4 2019

Feb 13, 2020

SELL
$37.87 - $45.37 $6.39 Million - $7.65 Million
-168,682 Reduced 8.89%
1,728,077 $78.1 Million
Q3 2019

Nov 14, 2019

SELL
$40.31 - $43.45 $1.21 Million - $1.3 Million
-29,955 Reduced 1.55%
1,896,759 $77.2 Million
Q2 2019

Aug 14, 2019

BUY
$34.91 - $42.98 $25.4 Million - $31.2 Million
726,934 Added 60.59%
1,926,714 $82.8 Million
Q1 2019

May 13, 2019

SELL
$32.91 - $40.75 $2.98 Million - $3.68 Million
-90,416 Reduced 7.01%
1,199,780 $46 Million
Q4 2018

Aug 28, 2019

BUY
$31.73 - $39.04 $12 Million - $14.8 Million
378,296 Added 41.48%
1,290,196 $45.6 Million
Q4 2018

Feb 13, 2019

BUY
$31.73 - $39.04 $24.4 Million - $30 Million
768,227 Added 534.71%
911,900 $32.2 Million
Q3 2018

Nov 13, 2018

SELL
$32.83 - $38.63 $622,062 - $731,961
-18,948 Reduced 11.65%
143,673 $5.53 Million
Q2 2018

Aug 13, 2018

BUY
$26.84 - $34.32 $4.36 Million - $5.58 Million
162,621 New
162,621 $5.32 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.